SDGR - Schrodinger, Inc.


13.03
-0.090   -0.691%

Share volume: 1,323,470
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%

$13.12
-0.09
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-01-2024 07-31-2024 11-12-2024 02-26-2025 05-07-2025 11-05-2025 02-25-2026
Total revenue 36.598 M 47.334 M 35.290 M 88.317 M 59.551 M 54.324 M 87.235 M
Cost of revenue 17.708 M 15.999 M 17.562 M 24.187 M 28.427 M 26.285 M 29.942 M
Gross profit 18.890 M 31.335 M 17.728 M 64.130 M 31.124 M 28.039 M 57.293 M
    65.88% -43.42% 261.74% -51.47% -9.91% 104.33%  
Operating expenses 86.323 M 84.064 M 75.801 M 75.138 M 71.646 M 64.462 M 64.112 M
Selling general and admin 35.712 M 33.229 M 24.824 M 25.776 M 25.802 M 21.705 M 22.713 M
Research and development 50.611 M 50.835 M 50.977 M 49.362 M 45.844 M 42.757 M 41.399 M
Total expenses 104.031 M 100.063 M 86.150 M 84.842 M 82.013 M 73.986 M 74.450 M
    -3.81% -13.90% -1.52% -3.33% -9.79% 0.63%  
Operating income -67.433 M -52.729 M -68.422 M -20.712 M -50.889 M -45.947 M -17.157 M
Ebit -67.433 M -52.729 M -38.226 M -39.253 M -59.780 M -32.633 M 32.973 M
Pretax income -54.268 M -53.964 M -38.226 M -39.253 M -59.780 M -32.633 M 32.973 M
    -0.56% -29.16% 2.69% 52.29% -45.41% -201.04%  
Income tax 456.000 K 83.000 K -90.000 K 963.000 K 28.000 K 162.000 K 462.000 K
Net income basic -54.724 M -54.047 M 0.000 0.000 0.000 0.000 0.000
    1.24% 100.00%          
Net income -54.724 M -54.047 M -38.136 M -40.216 M -59.808 M -32.795 M 32.511 M
    1.24% 29.44% -5.45% -48.72% 45.17% 199.13%